Haleon plc

Research Haleon plc (HLN) on Bullrun: market cap USD 41.50B, dividend yield 2.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 41.50B; dividend yield is 2.1%.

Peer valuation comparison

Latest dividend yield is 2.05% versus a Healthcare sector median of 1.84% (11.4% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025GBP 11.03BGBP 1.67BGBP 2.22B64.2%0.37GBP 1.26BGBP 8.58BGBP 16.43B
FY2024GBP 11.23BGBP 1.44BGBP 1.98B60.7%0.31GBP 2.20BGBP 10.10BGBP 16.17B
FY2023GBP 11.30BGBP 1.05BGBP 1.76B59.7%0.23GBP 994.00MGBP 9.43BGBP 16.61B
FY2022GBP 10.86BGBP 1.06BGBP 1.74B60.6%0.23GBP 606.00MGBP 10.44BGBP 16.33B
FY2021GBP 9.55BGBP 1.39BGBP 1.06B62.3%0.3GBP 347.00MGBP 991.00MGBP 26.36B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-09USD 41.50Bn/a2.1%0.2
20252025-12-31USD 45.02Bn/a1.8%0.18
20242024-12-31USD 43.13Bn/a1.7%0.16
20232023-12-29USD 38.00Bn/a1.3%0.11
20222022-12-30USD 36.94Bn/an/an/a

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.2 USD, yield 2.1%.

YearDividends/share
FY20250.18 GBP
FY20240.16 GBP
FY20230.11 GBP

About Haleon plc

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

ETFs that hold Haleon plc

Haleon plc is one of the ten largest holdings of 5 ETFs that investors in Europe can buy, most traded first:

ETFWeightTER
Xtrackers MSCI UK ESG UCITS ETF 1D2.51%0.18%
Amundi MSCI UK IMI SRI Climate Paris Aligned - UCITS ETF DR - EUR (C)4.85%0.18%
Inyova Impact Investing Fund3.02%0.95%
Amundi MSCI UK IMI SRI Climate Paris Aligned - UCITS ETF DR - GBP (C)4.85%0.18%
Amundi MSCI UK IMI SRI Climate Paris Aligned - UCITS ETF DR - EUR (D)4.85%0.18%

Related stock research

United Kingdom stocks United Kingdom Healthcare stocks A-Z stock index

Other Healthcare stocks

Kiniksa Pharmaceuticals International plc. - Class A (KNSA) 4BASEBIO UK SOCIETAS (4BB) Abingdon Health Plc (ABDX) Allergy Therapeutics (AGY) Advanced Medical Solutions Group plc (AMS.L) Aptamer Group PLC (APTA) Arecor Therapeutics plc (AREC.L) Autolus Therapeutics plc (AUTL) Avacta Group PLC (AVCT) Astrazeneca plc (AZN) Bicycle Therapeutics Plc (BCYC) Biodexa Pharmaceuticals Plc (BDRX)

Frequently asked questions

What is Haleon plc's market cap?

Haleon plc's market capitalization is USD 41.50B.

Does Haleon plc pay a dividend?

Haleon plc has a dividend yield of 2.1%.

What does Haleon plc do?

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.